Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor ...

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Please provide your email address to receive an email when new articles are posted on . A higher threshold for patient global assessment — 2 cm rather than 1 cm — increases agreement between Boolean ...

WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those with lingering low-level symptoms, a single-center study found -- casting ...

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Please provide your email address to receive an email when new articles are posted on . Tapering regimens were linked to significantly higher flare risk among patients in RA remission. The results ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to ...

Strong initial responses in 4 of 6 patients after many standard drugs had failed ...

Among patients with rheumatoid arthritis (RA) in clinical remission, patient-physician discordance when assessing disease activity may be associated with the inability to achieve remission. When ...

A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission. Led by the University ...